2-[bis(1-carboxyethyl)-[(E)-pentadec-1-enyl]azaniumyl]propanoate
C24H43NO6 — CID 177492526
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[bis(1-carboxyethyl)-[(E)-pentadec-1-enyl]azaniumyl]propanoate
2-[bis(1-carboxyethyl)-[(E)-pentadec-1-enyl]azaniumyl]propanoate (PubChem CID 177492526) has the molecular formula C24H43NO6 and a molecular weight of 441.61 g/mol. Its IUPAC name is 2-[bis(1-carboxyethyl)-[(E)-pentadec-1-enyl]azaniumyl]propanoate.
Molecular Properties
| Compound Name | 2-[bis(1-carboxyethyl)-[(E)-pentadec-1-enyl]azaniumyl]propanoate |
|---|---|
| PubChem CID | 177492526 |
| Molecular Formula | C24H43NO6 |
| Molecular Weight | 441.61 g/mol |
| Exact Mass | 441.31 |
| IUPAC Name | 2-[bis(1-carboxyethyl)-[(E)-pentadec-1-enyl]azaniumyl]propanoate |
| SMILES | CCCCCCCCCCCCC/C=C/[N+](C(C)C(=O)[O-])(C(C)C(=O)O)C(C)C(=O)O |
| InChI | InChI=1S/C24H43NO6/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-25(19(2)22(26)27,20(3)23(28)29)21(4)24(30)31/h17-21H,5-16H2,1-4H3,(H2-,26,27,28,29,30,31)/b18-17+ |
| InChIKey | QZDLYSQOVUPXGB-ISLYRVAYSA-N |
| XLogP | 4.10 |
| TPSA | 114.73 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 441.61 |
| LogP ≤ 5 | 4.10 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177492526 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.